These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7485806)

  • 1. [Postmenopausal atrophic colpitis--its local treatment with low-dose estradiol].
    Rachev E
    Akush Ginekol (Sofiia); 1995; 34(1):41-2. PubMed ID: 7485806
    [No Abstract]   [Full Text] [Related]  

  • 2. The comparison of hyaluronic acid vaginal tablets with estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.
    Ekin M; Yaşar L; Savan K; Temur M; Uhri M; Gencer I; Kıvanç E
    Arch Gynecol Obstet; 2011 Mar; 283(3):539-43. PubMed ID: 20135132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.
    Bachmann G; Lobo RA; Gut R; Nachtigall L; Notelovitz M
    Obstet Gynecol; 2008 Jan; 111(1):67-76. PubMed ID: 18165394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy.
    Dugal R; Hesla K; Sørdal T; Aase KH; Lilleeidet O; Wickstrøm E
    Acta Obstet Gynecol Scand; 2000 Apr; 79(4):293-7. PubMed ID: 10746845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma estrogen concentrations after oral and vaginal estrogen administration in women with atrophic vaginitis.
    Dorr MB; Nelson AL; Mayer PR; Ranganath RP; Norris PM; Helzner EC; Preston RA
    Fertil Steril; 2010 Nov; 94(6):2365-8. PubMed ID: 20466363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis.
    Chollet JA; Carter G; Meyn LA; Mermelstein F; Balk JL
    Menopause; 2009; 16(5):978-83. PubMed ID: 19390463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Safety of promestriene capsule used in postmenopausal atrophic vaginitis].
    Sun AJ; Lin SQ; Jing LH; Wang ZY; Ye JL; Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2009 Aug; 44(8):593-6. PubMed ID: 20003787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open-label randomized trial to determine the most effective regimen of vaginal estrogen to reduce the prevalence of atrophic changes reported in postmenopausal cervical smears.
    Bateson DJ; Weisberg E
    Menopause; 2009; 16(4):765-9. PubMed ID: 19407678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal estrogen preparations: a review of safety and efficacy for vaginal atrophy.
    Crandall C
    J Womens Health (Larchmt); 2002 Dec; 11(10):857-77. PubMed ID: 12626086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal estrogen therapy for the treatment of atrophic vaginitis.
    Lynch C
    J Womens Health (Larchmt); 2009 Oct; 18(10):1595-606. PubMed ID: 19788364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. By the way, doctor. My doctor prescribed a low-dose vaginal estrogen cream, applied twice a week, for atrophic vaginitis. I've heard this dose is so low that it carries no health risk. Do you agree?
    Robb-Nicholson C
    Harv Womens Health Watch; 2007 Nov; 15(3):7. PubMed ID: 18225330
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vagifem. A new low-dosage estradiol preparation for local treatment of postmenopausal urogenital atrophy].
    Eriksen PS; Rasmussen H
    Ugeskr Laeger; 1992 Apr; 154(16):1122-4. PubMed ID: 1523727
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaginal estrogen preparations for relief of atrophic vaginitis.
    Nothnagle M; Taylor JS
    Am Fam Physician; 2004 May; 69(9):2111-2. PubMed ID: 15152956
    [No Abstract]   [Full Text] [Related]  

  • 14. Local estrogen replacement therapy in postmenopausal atrophic vaginitis: efficacy and safety of low dose 17beta-estradiol vaginal tablets.
    Mainini G; Scaffa C; Rotondi M; Messalli EM; Quirino L; Ragucci A
    Clin Exp Obstet Gynecol; 2005; 32(2):111-3. PubMed ID: 16108394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis.
    Rioux JE; Devlin C; Gelfand MM; Steinberg WM; Hepburn DS
    Menopause; 2000; 7(3):156-61. PubMed ID: 10810960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose 17 beta-estradiol vaginal tablets in the treatment of atrophic vaginitis: a double-blind placebo controlled study.
    Eriksen PS; Rasmussen H
    Eur J Obstet Gynecol Reprod Biol; 1992 Apr; 44(2):137-44. PubMed ID: 1587379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estradiol absorption from vaginal tablets in postmenopausal women.
    Notelovitz M; Funk S; Nanavati N; Mazzeo M
    Obstet Gynecol; 2002 Apr; 99(4):556-62. PubMed ID: 12039110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
    Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "First uterine pass effect" is observed when estradiol is placed in the upper but not lower third of the vagina.
    Cicinelli E; De Ziegler D; Morgese S; Bulletti C; Luisi D; Schonauer LM
    Fertil Steril; 2004 May; 81(5):1414-6. PubMed ID: 15136116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ovestin cream in the treatment of postmenopausal vulvovaginal atrophy and atrophic vaginitis].
    Grcić R; Stavrić V; Knezević A; Kadija D; Perisić Z
    Med Pregl; 1987; 40(1-2):65-72. PubMed ID: 3657725
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.